Category: Latest News
-

Barclays advises waiting for deeper S&P 500 pullback before buying equities
Global equity markets are preparing for a volatile start after the United States and Israel launched Operation Judas Shield, a preemptive military strike on Iran that triggered rapid retaliation across the Middle East. Iran responded with missile attacks targeting U.S. military installations and allied locations across the region, with explosions reported in Dubai, Riyadh, Abu…
-

Kosmos Energy guides lower exploration spending, beats forecasts
Kosmos Energy (NYSE:KOS) released its 2026 outlook on Monday, forecasting exploration expenditures of between $10 million and $30 million — well below the Bloomberg consensus estimate of $48 million. The company expects annual production to average between 70,000 and 78,000 barrels of oil equivalent per day. Capital spending for 2026 is projected at approximately $350…
-

Compugen shares jump nearly 5% after strong Q4 earnings beat
Compugen Ltd. (NASDAQ:CGEN) shares climbed almost 5% in premarket trading on Monday after the company reported fourth-quarter results that far exceeded analyst expectations, supported by a strategic royalty monetization deal with AstraZeneca. The clinical-stage cancer immunotherapy developer posted adjusted earnings per share of $0.60 for the quarter, sharply outperforming the analyst consensus forecast of a…
-

Xeris Biopharma shares rise nearly 3% after Q4 earnings beat and strong 2026 outlook
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) shares gained nearly 3% in premarket trading on Monday after the company reported fourth-quarter results that topped analyst expectations and issued 2026 revenue guidance above consensus forecasts. The biopharmaceutical company posted adjusted earnings per share of $0.06 for the fourth quarter, exceeding analyst estimates of $0.02 by $0.04. Quarterly revenue…
-

Sealed Air tops Q4 forecasts on stronger revenue and earnings performance
Sealed Air Corporation (NYSE:SEE) reported fourth-quarter results on Monday that came in ahead of analyst expectations, with both revenue and earnings exceeding consensus forecasts. The company posted adjusted earnings per share of $0.77, surpassing the analyst estimate of $0.73. Shares were little changed following the announcement, edging up 0.05% in premarket trading. Quarterly revenue totaled…
-

Astrana Health shares rise more than 3% after earnings beat and upbeat outlook
Astrana Health, Inc. (NASDAQ:ASTH) shares gained over 3% in premarket trading on Monday after the healthcare management company reported fourth-quarter results that surpassed analyst expectations and pointed to continued growth momentum heading into 2026. The company posted adjusted earnings per share of $0.54 for the fourth quarter, significantly exceeding the analyst consensus forecast of $0.10…
-

uniQure shares plunge 45% after FDA setback on Huntington’s gene therapy
Shares of uniQure N.V. (NASDAQ:QURE) dropped 45% on Monday after the company revealed that the U.S. Food and Drug Administration declined to support its proposed regulatory pathway for the approval of AMT-130, an experimental gene therapy targeting Huntington’s disease. According to final minutes from a Type A meeting held on January 30, the FDA said…
-

Yatsen shares slide 12% after fourth-quarter earnings miss expectations
Yatsen Holding Limited (NYSE:YSG) shares fell nearly 12% in premarket trading on Monday after the China-based beauty company reported fourth-quarter results that came in below earnings expectations. The company posted adjusted earnings per ADS of $0.07 for the quarter, missing analyst forecasts despite delivering improved profitability compared with the prior year. Fourth-quarter revenue rose 20.1%…
-

Venture Global shares jump 7% after fourth-quarter earnings surpass expectations
Venture Global, Inc. (NYSE:VG) shares surged 7% in premarket trading on Monday after the liquefied natural gas exporter reported fourth-quarter results that exceeded profit forecasts, supported by a sharp increase in production volumes. The company posted adjusted earnings per share of $0.41 for the fourth quarter, ahead of analyst estimates of $0.35. Quarterly revenue totaled…
-

Norwegian Cruise Line slides after soft 2026 outlook despite Q4 earnings beat
Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) shares fell 7.8% in premarket trading after the company delivered stronger-than-expected fourth-quarter earnings but disappointed investors with weaker revenue and fiscal 2026 guidance that came in below market forecasts. The cruise operator reported adjusted earnings per share of $0.28 for the fourth quarter, ahead of analyst expectations of $0.26.…